These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23525799)

  • 1. Colorectal surveillance in Lynch syndrome families.
    de Vos tot Nederveen Cappel WH; Järvinen HJ; Lynch PM; Engel C; Mecklin JP; Vasen HF
    Fam Cancer; 2013 Jun; 12(2):261-5. PubMed ID: 23525799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of new endoscopic techniques in Lynch syndrome.
    Haanstra JF; Kleibeuker JH; Koornstra JJ
    Fam Cancer; 2013 Jun; 12(2):267-72. PubMed ID: 23420551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
    Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
    Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.
    Utsumi M; Tanakaya K; Mushiake Y; Kunitomo T; Yasuhara I; Taniguchi F; Arata T; Katsuda K; Aoki H; Takeuchi H
    World J Surg Oncol; 2017 Aug; 15(1):140. PubMed ID: 28764791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
    Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
    Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of death of mutation carriers in Finnish Lynch syndrome families.
    Pylvänäinen K; Lehtinen T; Kellokumpu I; Järvinen H; Mecklin JP
    Fam Cancer; 2012 Sep; 11(3):467-71. PubMed ID: 22684865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
    Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
    Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value-based healthcare in Lynch syndrome.
    Hennink SD; Hofland N; Gopie JP; van der Kaa C; de Koning K; Nielsen M; Tops C; Morreau H; de Vos tot Nederveen Cappel WH; Langers AM; Hardwick JC; Gaarenstroom KN; Tollenaar RA; Veenendaal RA; Tibben A; Wijnen J; van Heck M; van Asperen C; Roukema AJ; Hommes DW; Hes FJ; Vasen HF
    Fam Cancer; 2013 Jun; 12(2):347-54. PubMed ID: 23681793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
    Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
    Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
    Stoffel EM
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.